This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Intas Pharmaceuticals Limited. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Innovator in Pharmaceutical Solutions - Chandresh Chhatbar
Introduction
Chandresh Chhatbar, based in Sanand Ahmedabad, India, is a distinguished inventor with notable contributions to the pharmaceutical industry. With three patents to his name, Chhatbar is recognized for his innovative approaches in creating effective drug formulations.
Latest Patents
Chhatbar's latest patents include a lyophilized pharmaceutical composition of Fc-peptide fusion protein, which presents a novel and thermostable formulation of Romiplostim. This composition effectively incorporates a buffer, bulking agent, stabilizer, and surfactant within a pH range of 4.0-6.0. Additionally, he has developed a liquid pharmaceutical composition of adalimumab, comprising an anti-TNFα antibody, a buffer, a stabilizer, and a surfactant, aimed at enhancing the stability and efficacy of this important therapeutic agent.
Career Highlights
Currently, Chandresh Chhatbar is employed at Intas Pharmaceuticals Limited, where he applies his expertise to improve pharmaceutical formulations. His role involves research and development, focusing on creating advanced solutions that meet the needs of patients.
Collaborations
At Intas Pharmaceuticals, Chhatbar collaborates with talented colleagues, including Vijaykant Pandey and Himanshu Gadgil. This synergy fosters an innovative environment that drives the development of effective pharmaceutical products.
Conclusion
Chandresh Chhatbar exemplifies the spirit of innovation in the pharmaceutical sector. His contributions through his patents not only reflect his dedication to his craft but also play a vital role in enhancing treatment options for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile